調査レポート | • レポートコード：QYR2104Z5012 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、むずむず脚症候群のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物療法、非薬物療法）、用途別市場規模（35歳以下、35〜50歳、50歳以上）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・むずむず脚症候群の市場動向 ・企業の競争状況、市場シェア ・むずむず脚症候群の種類別市場規模（薬物療法、非薬物療法） ・むずむず脚症候群の用途別市場規模（35歳以下、35〜50歳、50歳以上） ・むずむず脚症候群の北米市場規模2016-2027（アメリカ、カナダ） ・むずむず脚症候群のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・むずむず脚症候群のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・むずむず脚症候群の中南米市場規模2016-2027（メキシコ、ブラジル） ・むずむず脚症候群の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GlaxoSmithKline plc.、Ligand Pharmaceuticals Incorporated、axxonis Pharma AG、Kyowa Hakko Kirin、Jazz Pharmaceuticals、Omeros Corporation、Manhattan Pharmaceuticals、Boehringer Ingelheim GmbH、UCB SA） ・結論 |
Restless legs syndrome (RLS) is a neurological disease. RLS is also called as Willis-Ekbom disease. Patients suffering from RLS disease have an irresistible desire to move their feet. The continual movement of the legs leads to pain in the limbs, which leads to the unusual sleep pattern of patients.
Market Analysis and Insights: Global Restless Legs Syndrome Market
The global Restless Legs Syndrome market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Restless Legs Syndrome market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Restless Legs Syndrome market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Restless Legs Syndrome market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Restless Legs Syndrome market.
Global Restless Legs Syndrome Scope and Market Size
Restless Legs Syndrome market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Restless Legs Syndrome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Pharmacological Therapy
Non-Pharmacological Therapy
Segment by Application
Below 35 YearsOld
35-50 Years Old
Above50 YearsOld
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
GlaxoSmithKline plc.
Ligand Pharmaceuticals Incorporated
axxonis Pharma AG
Kyowa Hakko Kirin
Jazz Pharmaceuticals
Omeros Corporation
Manhattan Pharmaceuticals
Boehringer Ingelheim GmbH
UCB SA
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Restless Legs Syndrome Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Pharmacological Therapy
1.2.3 Non-Pharmacological Therapy
1.3 Market by Application
1.3.1 Global Restless Legs Syndrome Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Below 35 YearsOld
1.3.3 35-50 Years Old
1.3.4 Above50 YearsOld
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Restless Legs Syndrome Market Perspective (2016-2027)
2.2 Restless Legs Syndrome Growth Trends by Regions
2.2.1 Restless Legs Syndrome Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Restless Legs Syndrome Historic Market Share by Regions (2016-2021)
2.2.3 Restless Legs Syndrome Forecasted Market Size by Regions (2022-2027)
2.3 Restless Legs Syndrome Industry Dynamic
2.3.1 Restless Legs Syndrome Market Trends
2.3.2 Restless Legs Syndrome Market Drivers
2.3.3 Restless Legs Syndrome Market Challenges
2.3.4 Restless Legs Syndrome Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Restless Legs Syndrome Players by Revenue
3.1.1 Global Top Restless Legs Syndrome Players by Revenue (2016-2021)
3.1.2 Global Restless Legs Syndrome Revenue Market Share by Players (2016-2021)
3.2 Global Restless Legs Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Restless Legs Syndrome Revenue
3.4 Global Restless Legs Syndrome Market Concentration Ratio
3.4.1 Global Restless Legs Syndrome Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Restless Legs Syndrome Revenue in 2020
3.5 Restless Legs Syndrome Key Players Head office and Area Served
3.6 Key Players Restless Legs Syndrome Product Solution and Service
3.7 Date of Enter into Restless Legs Syndrome Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Restless Legs Syndrome Breakdown Data by Type
4.1 Global Restless Legs Syndrome Historic Market Size by Type (2016-2021)
4.2 Global Restless Legs Syndrome Forecasted Market Size by Type (2022-2027)
5 Restless Legs Syndrome Breakdown Data by Application
5.1 Global Restless Legs Syndrome Historic Market Size by Application (2016-2021)
5.2 Global Restless Legs Syndrome Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Restless Legs Syndrome Market Size (2016-2027)
6.2 North America Restless Legs Syndrome Market Size by Type
6.2.1 North America Restless Legs Syndrome Market Size by Type (2016-2021)
6.2.2 North America Restless Legs Syndrome Market Size by Type (2022-2027)
6.2.3 North America Restless Legs Syndrome Market Size by Type (2016-2027)
6.3 North America Restless Legs Syndrome Market Size by Application
6.3.1 North America Restless Legs Syndrome Market Size by Application (2016-2021)
6.3.2 North America Restless Legs Syndrome Market Size by Application (2022-2027)
6.3.3 North America Restless Legs Syndrome Market Size by Application (2016-2027)
6.4 North America Restless Legs Syndrome Market Size by Country
6.4.1 North America Restless Legs Syndrome Market Size by Country (2016-2021)
6.4.2 North America Restless Legs Syndrome Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Restless Legs Syndrome Market Size (2016-2027)
7.2 Europe Restless Legs Syndrome Market Size by Type
7.2.1 Europe Restless Legs Syndrome Market Size by Type (2016-2021)
7.2.2 Europe Restless Legs Syndrome Market Size by Type (2022-2027)
7.2.3 Europe Restless Legs Syndrome Market Size by Type (2016-2027)
7.3 Europe Restless Legs Syndrome Market Size by Application
7.3.1 Europe Restless Legs Syndrome Market Size by Application (2016-2021)
7.3.2 Europe Restless Legs Syndrome Market Size by Application (2022-2027)
7.3.3 Europe Restless Legs Syndrome Market Size by Application (2016-2027)
7.4 Europe Restless Legs Syndrome Market Size by Country
7.4.1 Europe Restless Legs Syndrome Market Size by Country (2016-2021)
7.4.2 Europe Restless Legs Syndrome Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Restless Legs Syndrome Market Size (2016-2027)
8.2 Asia-Pacific Restless Legs Syndrome Market Size by Type
8.2.1 Asia-Pacific Restless Legs Syndrome Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Restless Legs Syndrome Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Restless Legs Syndrome Market Size by Type (2016-2027)
8.3 Asia-Pacific Restless Legs Syndrome Market Size by Application
8.3.1 Asia-Pacific Restless Legs Syndrome Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Restless Legs Syndrome Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Restless Legs Syndrome Market Size by Application (2016-2027)
8.4 Asia-Pacific Restless Legs Syndrome Market Size by Region
8.4.1 Asia-Pacific Restless Legs Syndrome Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Restless Legs Syndrome Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Restless Legs Syndrome Market Size (2016-2027)
9.2 Latin America Restless Legs Syndrome Market Size by Type
9.2.1 Latin America Restless Legs Syndrome Market Size by Type (2016-2021)
9.2.2 Latin America Restless Legs Syndrome Market Size by Type (2022-2027)
9.2.3 Latin America Restless Legs Syndrome Market Size by Type (2016-2027)
9.3 Latin America Restless Legs Syndrome Market Size by Application
9.3.1 Latin America Restless Legs Syndrome Market Size by Application (2016-2021)
9.3.2 Latin America Restless Legs Syndrome Market Size by Application (2022-2027)
9.3.3 Latin America Restless Legs Syndrome Market Size by Application (2016-2027)
9.4 Latin America Restless Legs Syndrome Market Size by Country
9.4.1 Latin America Restless Legs Syndrome Market Size by Country (2016-2021)
9.4.2 Latin America Restless Legs Syndrome Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Restless Legs Syndrome Market Size (2016-2027)
10.2 Middle East & Africa Restless Legs Syndrome Market Size by Type
10.2.1 Middle East & Africa Restless Legs Syndrome Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Restless Legs Syndrome Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Restless Legs Syndrome Market Size by Type (2016-2027)
10.3 Middle East & Africa Restless Legs Syndrome Market Size by Application
10.3.1 Middle East & Africa Restless Legs Syndrome Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Restless Legs Syndrome Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Restless Legs Syndrome Market Size by Application (2016-2027)
10.4 Middle East & Africa Restless Legs Syndrome Market Size by Country
10.4.1 Middle East & Africa Restless Legs Syndrome Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Restless Legs Syndrome Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline plc.
11.1.1 GlaxoSmithKline plc. Company Details
11.1.2 GlaxoSmithKline plc. Business Overview
11.1.3 GlaxoSmithKline plc. Restless Legs Syndrome Introduction
11.1.4 GlaxoSmithKline plc. Revenue in Restless Legs Syndrome Business (2016-2021)
11.1.5 GlaxoSmithKline plc. Recent Development
11.2 Ligand Pharmaceuticals Incorporated
11.2.1 Ligand Pharmaceuticals Incorporated Company Details
11.2.2 Ligand Pharmaceuticals Incorporated Business Overview
11.2.3 Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Introduction
11.2.4 Ligand Pharmaceuticals Incorporated Revenue in Restless Legs Syndrome Business (2016-2021)
11.2.5 Ligand Pharmaceuticals Incorporated Recent Development
11.3 axxonis Pharma AG
11.3.1 axxonis Pharma AG Company Details
11.3.2 axxonis Pharma AG Business Overview
11.3.3 axxonis Pharma AG Restless Legs Syndrome Introduction
11.3.4 axxonis Pharma AG Revenue in Restless Legs Syndrome Business (2016-2021)
11.3.5 axxonis Pharma AG Recent Development
11.4 Kyowa Hakko Kirin
11.4.1 Kyowa Hakko Kirin Company Details
11.4.2 Kyowa Hakko Kirin Business Overview
11.4.3 Kyowa Hakko Kirin Restless Legs Syndrome Introduction
11.4.4 Kyowa Hakko Kirin Revenue in Restless Legs Syndrome Business (2016-2021)
11.4.5 Kyowa Hakko Kirin Recent Development
11.5 Jazz Pharmaceuticals
11.5.1 Jazz Pharmaceuticals Company Details
11.5.2 Jazz Pharmaceuticals Business Overview
11.5.3 Jazz Pharmaceuticals Restless Legs Syndrome Introduction
11.5.4 Jazz Pharmaceuticals Revenue in Restless Legs Syndrome Business (2016-2021)
11.5.5 Jazz Pharmaceuticals Recent Development
11.6 Omeros Corporation
11.6.1 Omeros Corporation Company Details
11.6.2 Omeros Corporation Business Overview
11.6.3 Omeros Corporation Restless Legs Syndrome Introduction
11.6.4 Omeros Corporation Revenue in Restless Legs Syndrome Business (2016-2021)
11.6.5 Omeros Corporation Recent Development
11.7 Manhattan Pharmaceuticals
11.7.1 Manhattan Pharmaceuticals Company Details
11.7.2 Manhattan Pharmaceuticals Business Overview
11.7.3 Manhattan Pharmaceuticals Restless Legs Syndrome Introduction
11.7.4 Manhattan Pharmaceuticals Revenue in Restless Legs Syndrome Business (2016-2021)
11.7.5 Manhattan Pharmaceuticals Recent Development
11.8 Boehringer Ingelheim GmbH
11.8.1 Boehringer Ingelheim GmbH Company Details
11.8.2 Boehringer Ingelheim GmbH Business Overview
11.8.3 Boehringer Ingelheim GmbH Restless Legs Syndrome Introduction
11.8.4 Boehringer Ingelheim GmbH Revenue in Restless Legs Syndrome Business (2016-2021)
11.8.5 Boehringer Ingelheim GmbH Recent Development
11.9 UCB SA
11.9.1 UCB SA Company Details
11.9.2 UCB SA Business Overview
11.9.3 UCB SA Restless Legs Syndrome Introduction
11.9.4 UCB SA Revenue in Restless Legs Syndrome Business (2016-2021)
11.9.5 UCB SA Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Restless Legs Syndrome Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Pharmacological Therapy
Table 3. Key Players of Non-Pharmacological Therapy
Table 4. Global Restless Legs Syndrome Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Restless Legs Syndrome Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Restless Legs Syndrome Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Restless Legs Syndrome Market Share by Regions (2016-2021)
Table 8. Global Restless Legs Syndrome Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Restless Legs Syndrome Market Share by Regions (2022-2027)
Table 10. Restless Legs Syndrome Market Trends
Table 11. Restless Legs Syndrome Market Drivers
Table 12. Restless Legs Syndrome Market Challenges
Table 13. Restless Legs Syndrome Market Restraints
Table 14. Global Restless Legs Syndrome Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Restless Legs Syndrome Market Share by Players (2016-2021)
Table 16. Global Top Restless Legs Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Restless Legs Syndrome as of 2020)
Table 17. Ranking of Global Top Restless Legs Syndrome Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Restless Legs Syndrome Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Restless Legs Syndrome Product Solution and Service
Table 21. Date of Enter into Restless Legs Syndrome Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Restless Legs Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Restless Legs Syndrome Revenue Market Share by Type (2016-2021)
Table 25. Global Restless Legs Syndrome Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Restless Legs Syndrome Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Restless Legs Syndrome Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Restless Legs Syndrome Revenue Market Share by Application (2016-2021)
Table 29. Global Restless Legs Syndrome Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Restless Legs Syndrome Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Restless Legs Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Restless Legs Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Restless Legs Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Restless Legs Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Restless Legs Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Restless Legs Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Restless Legs Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Restless Legs Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Restless Legs Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Restless Legs Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Restless Legs Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Restless Legs Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Restless Legs Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Restless Legs Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Restless Legs Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Restless Legs Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Restless Legs Syndrome Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Restless Legs Syndrome Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Restless Legs Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Restless Legs Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Restless Legs Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Restless Legs Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Restless Legs Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Restless Legs Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Restless Legs Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Restless Legs Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Restless Legs Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Restless Legs Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Restless Legs Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Restless Legs Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 61. GlaxoSmithKline plc. Company Details
Table 62. GlaxoSmithKline plc. Business Overview
Table 63. GlaxoSmithKline plc. Restless Legs Syndrome Product
Table 64. GlaxoSmithKline plc. Revenue in Restless Legs Syndrome Business (2016-2021) & (US$ Million)
Table 65. GlaxoSmithKline plc. Recent Development
Table 66. Ligand Pharmaceuticals Incorporated Company Details
Table 67. Ligand Pharmaceuticals Incorporated Business Overview
Table 68. Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Product
Table 69. Ligand Pharmaceuticals Incorporated Revenue in Restless Legs Syndrome Business (2016-2021) & (US$ Million)
Table 70. Ligand Pharmaceuticals Incorporated Recent Development
Table 71. axxonis Pharma AG Company Details
Table 72. axxonis Pharma AG Business Overview
Table 73. axxonis Pharma AG Restless Legs Syndrome Product
Table 74. axxonis Pharma AG Revenue in Restless Legs Syndrome Business (2016-2021) & (US$ Million)
Table 75. axxonis Pharma AG Recent Development
Table 76. Kyowa Hakko Kirin Company Details
Table 77. Kyowa Hakko Kirin Business Overview
Table 78. Kyowa Hakko Kirin Restless Legs Syndrome Product
Table 79. Kyowa Hakko Kirin Revenue in Restless Legs Syndrome Business (2016-2021) & (US$ Million)
Table 80. Kyowa Hakko Kirin Recent Development
Table 81. Jazz Pharmaceuticals Company Details
Table 82. Jazz Pharmaceuticals Business Overview
Table 83. Jazz Pharmaceuticals Restless Legs Syndrome Product
Table 84. Jazz Pharmaceuticals Revenue in Restless Legs Syndrome Business (2016-2021) & (US$ Million)
Table 85. Jazz Pharmaceuticals Recent Development
Table 86. Omeros Corporation Company Details
Table 87. Omeros Corporation Business Overview
Table 88. Omeros Corporation Restless Legs Syndrome Product
Table 89. Omeros Corporation Revenue in Restless Legs Syndrome Business (2016-2021) & (US$ Million)
Table 90. Omeros Corporation Recent Development
Table 91. Manhattan Pharmaceuticals Company Details
Table 92. Manhattan Pharmaceuticals Business Overview
Table 93. Manhattan Pharmaceuticals Restless Legs Syndrome Product
Table 94. Manhattan Pharmaceuticals Revenue in Restless Legs Syndrome Business (2016-2021) & (US$ Million)
Table 95. Manhattan Pharmaceuticals Recent Development
Table 96. Boehringer Ingelheim GmbH Company Details
Table 97. Boehringer Ingelheim GmbH Business Overview
Table 98. Boehringer Ingelheim GmbH Revenue in Restless Legs Syndrome Business (2016-2021) & (US$ Million)
Table 99. Boehringer Ingelheim GmbH Recent Development
Table 100. UCB SA Company Details
Table 101. UCB SA Business Overview
Table 102. UCB SA Restless Legs Syndrome Product
Table 103. UCB SA Revenue in Restless Legs Syndrome Business (2016-2021) & (US$ Million)
Table 104. UCB SA Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Restless Legs Syndrome Market Share by Type: 2020 VS 2027
Figure 2. Pharmacological Therapy Features
Figure 3. Non-Pharmacological Therapy Features
Figure 4. Global Restless Legs Syndrome Market Share by Application: 2020 VS 2027
Figure 5. Below 35 YearsOld Case Studies
Figure 6. 35-50 Years Old Case Studies
Figure 7. Above50 YearsOld Case Studies
Figure 8. Restless Legs Syndrome Report Years Considered
Figure 9. Global Restless Legs Syndrome Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Restless Legs Syndrome Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Restless Legs Syndrome Market Share by Regions: 2020 VS 2027
Figure 12. Global Restless Legs Syndrome Market Share by Regions (2022-2027)
Figure 13. Global Restless Legs Syndrome Market Share by Players in 2020
Figure 14. Global Top Restless Legs Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Restless Legs Syndrome as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Restless Legs Syndrome Revenue in 2020
Figure 16. Global Restless Legs Syndrome Revenue Market Share by Type (2016-2021)
Figure 17. Global Restless Legs Syndrome Revenue Market Share by Type (2022-2027)
Figure 18. North America Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Restless Legs Syndrome Market Share by Type (2016-2027)
Figure 20. North America Restless Legs Syndrome Market Share by Application (2016-2027)
Figure 21. North America Restless Legs Syndrome Market Share by Country (2016-2027)
Figure 22. United States Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Restless Legs Syndrome Market Share by Type (2016-2027)
Figure 26. Europe Restless Legs Syndrome Market Share by Application (2016-2027)
Figure 27. Europe Restless Legs Syndrome Market Share by Country (2016-2027)
Figure 28. Germany Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Restless Legs Syndrome Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Restless Legs Syndrome Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Restless Legs Syndrome Market Share by Region (2016-2027)
Figure 38. China Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Restless Legs Syndrome Market Share by Type (2016-2027)
Figure 46. Latin America Restless Legs Syndrome Market Share by Application (2016-2027)
Figure 47. Latin America Restless Legs Syndrome Market Share by Country (2016-2027)
Figure 48. Mexico Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Restless Legs Syndrome Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Restless Legs Syndrome Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Restless Legs Syndrome Market Share by Country (2016-2027)
Figure 54. Turkey Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. GlaxoSmithKline plc. Revenue Growth Rate in Restless Legs Syndrome Business (2016-2021)
Figure 58. Ligand Pharmaceuticals Incorporated Revenue Growth Rate in Restless Legs Syndrome Business (2016-2021)
Figure 59. axxonis Pharma AG Revenue Growth Rate in Restless Legs Syndrome Business (2016-2021)
Figure 60. Kyowa Hakko Kirin Revenue Growth Rate in Restless Legs Syndrome Business (2016-2021)
Figure 61. Jazz Pharmaceuticals Revenue Growth Rate in Restless Legs Syndrome Business (2016-2021)
Figure 62. Omeros Corporation Revenue Growth Rate in Restless Legs Syndrome Business (2016-2021)
Figure 63. Manhattan Pharmaceuticals Revenue Growth Rate in Restless Legs Syndrome Business (2016-2021)
Figure 64. Boehringer Ingelheim GmbH Revenue Growth Rate in Restless Legs Syndrome Business (2016-2021)
Figure 65. UCB SA Revenue Growth Rate in Restless Legs Syndrome Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
世界のむずむず脚症候群市場規模・現状・予測（2021年-2027年） Restless legs syndrome (RLS) is a neurological disease. RLS is also called as Willis-Ekbom disease. Patients suffering from RLS disease have an irresistible desire to move their feet. The continual movement of the legs leads to pain in the limbs, which leads to the unusual sleep pattern of patients.…- 世界のゾリンジャー-エリソン症候群検査市場規模・現状・予測（2021年-2027年） Zollinger-Ellison syndrome is a rare condition in which one or more tumors form in your pancreas or the upper part of your small intestine (duodenum). Market Analysis and Insights: Global Zollinger - Ellison Syndrome Testing Market The global Zollinger - Ellison Syndrome Testing market size is proj…
- 世界のアスペルガー症候群治療市場規模・現状・予測（2021年-2027年） The Asperger syndrome is a type of developmental disorders known as Autistic Spectrum Disorder (ASD). These disorders initiate in childhood and stay with individuals until their adult life. Children with the Asperger syndrome function better than those with autism, and they have normal intelligence …
- 世界の腫瘍随伴症候群治療市場規模・現状・予測（2021年-2027年） A paraneoplastic syndrome is a rare group of disorder that is triggered by an abnormal immune system response caused by the neoplasm. This syndrome mostly occurs when cancer-fighting antibodies mistakenly attack normal cells in the nervous system. The prevalence of this disorder can be typically see…
- 世界の急性冠症候群（ACS）市場規模・現状・予測（2021年-2027年） Acute coronary syndrome (ACS) is a syndrome (set of signs and symptoms) due to decreased blood flow in the coronary arteries such that part of the heart muscle is unable to function properly or dies. The most common symptom is chest pain, often radiating to the left shoulder or angle of the jaw, cru…